Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries
- 15 October 2004
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 94 (8), 1050-1054
- https://doi.org/10.1016/j.amjcard.2004.06.066
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Intravascular UltrasoundCirculation, 2001
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- 7E3 Monoclonal Antibody Directed Against the Platelet Glycoprotein IIb/IIIa Cross-reacts With the Leukocyte Integrin Mac-1 and Blocks Adhesion to Fibrinogen and ICAM-1Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".Journal of Clinical Investigation, 1996
- Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic StrategyCirculation, 1995
- Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular MedicineNew England Journal of Medicine, 1995
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.Circulation, 1989